Real-World Clinical Outcomes of Ujvira® (Trastuzumab Emtansine Biosimilar) in HER2-Positive Breast Cancer: A Retrospective Observational Study in Indian Patients. J. Can. Res. Updates. 2025;14:114-120. doi:10.30683/1929-2279.2025.14.13